LGN · Legence Corp.

Current Thesis

Legence's data-center contracting story faces a price-repair test: a weekly close above the August reference close of $59.37 before another weekly close below $54 would establish the recovery case. The company's 2026-08-13 results supplied the operating evidence: quarterly revenue of $1.26 billion and full-year revenue guidance raised to $4.7–4.8 billion. Those figures support the business narrative; they do not establish a share-price recovery.

The material change since the 2026-09-05 note is the recovery above the April secondary-offering price of $54. The adjusted market close was $55.80 on 2026-09-18, compared with $52.97 on 2026-09-04. The earlier weekly breach remains an invalidation of the earlier thesis; the latest close creates a separate, tentative recovery test.

As an inference, the narrative is maturing — the guidance increase dates to 2026-08-13, Bernstein reiterated its $103 target on 2026-09-03, and the company's release index still lists August results as its latest announcement when checked on 2026-09-19. That evidence establishes an existing story, without establishing renewed participation. Analyst record, company releases.

Bullish and bearish views on Legence Corp.

The model's bull view on Legence Corp. (LGN), in brief: Growth extends beyond acquisitions. Legence's 2026-08-13 release reported second-quarter revenue of $1.26 billion, up 110.7% year over year, with approximately 60% growth excluding The Bowers Group acquisition. Orders support the raised outlook. Backlog and awarded contracts… The bear view: The broader decline remains substantial. Both cases follow in full.

Bull Case

• Growth extends beyond acquisitions. Legence's 2026-08-13 release reported second-quarter revenue of $1.26 billion, up 110.7% year over year, with approximately 60% growth excluding The Bowers Group acquisition.
• Orders support the raised outlook. Backlog and awarded contracts totaled $5.67 billion at 2026-06-30. On 2026-08-13, management raised full-year revenue guidance to $4.7–4.8 billion and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) guidance to $565–585 million.
• The broken reference was reclaimed. The adjusted 2026-09-18 close of $55.80 exceeded the $54 secondary-offering price associated with the transaction that closed on 2026-04-09. This is a measured recovery of a public reference level, not evidence that a durable base has formed.

Financial figures are attributed to Legence's 2026-08-13 results release.

Bear Case

• The broader decline remains substantial. At 2026-09-18, adjusted daily bars showed the shares 45.4% below their $102.27 trailing-year high and down 36.7% over three months. The latest close alone cannot establish a reversal.
• Reported losses qualify adjusted earnings. The 2026-08-13 results reported second-quarter adjusted EBITDA of $154.6 million alongside a $27.8 million net loss attributable to Legence, including approximately $41.1 million of impairments.
• Positive coverage predates the rebound. StockAnalysis's record checked on 2026-09-19 lists Bernstein's 2026-09-03 $103 target and Guggenheim's 2026-08-26 $115 target. These are analysts' expectations; they provide no measurement of subsequent investor demand. Analyst record.

Setup & Price Structure

The adjusted market close of $55.80 on 2026-09-18 stands above the $54 April offering reference but below the $59.37 close recorded on 2026-08-21. A weekly close above $59.37 defines completion of this limited price-repair case; a weekly close below $54 invalidates it. Neither condition promises a return to the trailing-year high.

The 14-period relative strength index (RSI) measured 54.5 on 2026-09-18, versus 13.5 on 2026-09-04. These endpoints show a momentum recovery, but the sample is too small to support a claim about persistence. A current moving-average level and a dated ownership-flow series are missing, so neither trend support nor crowding can be quantified.

The positioning observable is historical supply: the secondary offering closed on 2026-04-09 at the supplied $54 offering price. The company's release index checked on 2026-09-19 does not establish a new September placement. The low-conviction forecast reflects the prior breach and the absence of evidence that the rebound is durable. Company release index.

Catalyst Calendar (next 30 days)

• 2026-10-01 — Wolfe Industrial Conference. Legence's event calendar lists attendance in New York. Any disclosed guidance revision would change the operating assessment; attendance alone does not confirm orders or earnings. Company calendar.
• ~2026-11-12, estimated — Third-quarter results. This later operating test remains an estimate from the prior coverage; the company calendar checked on 2026-09-19 does not confirm the date. The 2026-08-13 outlook specifies third-quarter revenue of $1.23–1.28 billion and adjusted EBITDA of $150–160 million. Results below those floors would contradict the expected conversion of demand into earnings.

What Would Change Our Mind

Failure to retain the reclaimed April offering reference would end the recovery case: a weekly close below $54 is the observable price invalidation. The 2026-09-04 close of $52.97 already demonstrated that this reference can fail; the 2026-09-18 recovery does not erase that event.

Operating confirmation requires the next quarterly results to meet the revenue and adjusted EBITDA floors published on 2026-08-13. Revenue below $1.23 billion, adjusted EBITDA below $150 million, or a reduction in the $4.7–4.8 billion annual revenue outlook would weaken the contracting thesis independently of price.

Correlation Notes

This remains a single-name recovery case. The peer comparison cited in the 2026-09-05 coverage used 2026-08-26 reporting of Comfort Systems' $14.1 billion backlog and EMCOR's $17.14 billion remaining performance obligations. Those observations provide industry-demand context, but they are different measures and do not establish a return correlation with Legence.

A contemporaneous peer-return series is missing for 2026-09-18. The supplied observations are insufficient to attribute Legence's rebound to a broader contractor move.